Shandong Anhong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is BEXAROTENE, with a corresponding US DMF Number 42489.
Remarkably, this DMF maintains an Active status since its submission on September 28, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 04, 2025, and payment made on September 18, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II